Emicizumab-induced photosensitivity.
Pedro AsensiMercedes Rodríguez SernaPilar Lloret MadridJürgen Solís RuizAna Rosa Cid HaroSantiago Bonanad BoixSaturnino Haya GuaitaPublished in: TH open : companion journal to thrombosis and haemostasis (2022)
Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our knowledge, this side effect had not been communicated until present.